Suppr超能文献

[Proton-pump inhibitors and risk of kidney disease].

作者信息

Paquot François, Krzesinski Jean-Marie

机构信息

Service de néphrologie, dialyse et transplantation, Centre hospitalier universitaire de Liège, Sart Tilman, Université de Liège, 4000 Liège, Belgique.

出版信息

Rev Med Suisse. 2017 Aug 23;13(571):1427-1430.

Abstract

Regarded as safe and effective for management of upper peptic ulcer disease due to gastric acid secretion, the proton pump inhibitors are among the most commonly prescribed drugs. Their use, however, is not without concerns. Acute kidney injury, mainly due to acute interstitial nephritis, could happen 1.5 to 2 times more frequently when using these drugs. Moreover, a risk for chronic kidney disease has also be noted with proton pump inhibitor use (1.15 to 1.8 increased risk), although biases may exist due to confounding factors related to the observational nature of the studies. So, caution is required before available results from good prospective randomized studies are available. Renal function should be checked when using these medications and timely cessation should be advised when there is no more clear indication for use.

摘要

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验